Citigroup »

Aziyo Biologics shares owned by Citigroup

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-12-31 $36k 9.7k 3.74
2024-09-30 $71k 19k 3.81
2021-03-31 $2.0k 149 13.42
2020-12-31 $3.0k 250 12.00

More positions owned by Citigroup

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial (XLF)

View all positions for Citigroup

Top funds holding Aziyo Biologics

Nantahala Capital Management
AIGH Capital Management
Silverarc Capital Management
Birchview Capital
Knollwood Investment Advisory
Vanguard Group
Perkins Capital Management
Alyeska Investment Group
Geode Capital Management
Kennedy Capital Management
683 Capital Management
BlackRock
Qube Research & Technologies
Renaissance Technologies
Millennium Management

View all funds holding Aziyo Biologics